Skip to main content
. 2010 Dec 1;85(4):1793–1803. doi: 10.1128/JVI.01924-10

FIG. 10.

FIG. 10.

Dose-dependent survival of MAb 2c-treated immunodeficient mice. NOD/SCID mice received different single dosages of MAb 2c intravenously 24 h before intravaginal challenge with 1 × 106 TCID50 HSV-1 (n = 7 animals per group for PBS; n = 9 for all other groups).